EXACT Sciences Corporation

Exact Sciences is a molecular diagnostics company focused on colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Stool-based DNA (sDNA) technology is included in the colorectal cancer screening guidelines of the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer.
Type
Public
HQ
Madison, US
Founded
1995
Size (employees)
736 (est)+9%
EXACT Sciences Corporation was founded in 1995 and is headquartered in Madison, US

EXACT Sciences Corporation Office Locations

EXACT Sciences Corporation has an office in Madison
Madison, US (HQ)
441 Charmany Dr

EXACT Sciences Corporation Data and Metrics

EXACT Sciences Corporation Financial Metrics

EXACT Sciences Corporation's revenue was reported to be $99.4 m in FY, 2016 which is a 152% increase from the previous period.
USD

Revenue (FY, 2016)

99.4 m

Revenue growth (FY, 2015 - FY, 2016), %

152%

Gross profit (FY, 2016)

54.2 m

Gross profit margin (FY, 2016), %

55%

Net income (FY, 2016)

(167.2 m)

EBIT (FY, 2016)

(169 m)

Market capitalization (27-Jun-2017)

3.8 b

Closing share price (27-Jun-2017)

34.9

Cash (31-Dec-2016)

48.9 m
EXACT Sciences Corporation's current market capitalization is $3.8 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

4.1 m1.8 m39.4 m99.4 m

Revenue growth, %

(57%)2093%152%

Cost of goods sold

4.3 m24.5 m45.2 m

Gross profit

(2.5 m)14.9 m54.2 m

Gross profit Margin, %

(141%)38%55%

Operating expense total

50.9 m98 m174 m223.2 m

EBIT

(46.8 m)(100.5 m)(159.1 m)(169 m)

EBIT margin, %

(1128%)(5592%)(403%)(170%)

Interest expense

69 k51 k6 k213 k

Net Income

(46.5 m)(100 m)(157.8 m)(167.2 m)
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

12.9 m58.1 m41.1 m48.9 m

Accounts Receivable

1.4 m8.5 m

Inventories

2.2 m3.5 m7.6 m7.1 m

Current Assets

135.5 m291.7 m326.1 m333.6 m

PP&E

11.2 m

Total Assets

146.6 m311.6 m364.3 m377 m

Accounts Payable

761 k2.6 m3.3 m710 k

Current Liabilities

7.8 m17.5 m26.7 m30.7 m

Additional Paid-in Capital

455.2 m709 m904.9 m1.1 b

Retained Earnings

(320.8 m)(420.8 m)(578.6 m)(745.8 m)

Total Equity

135.3 m289 m326.9 m335.3 m

Financial Leverage

1.1 x1.1 x1.1 x1.1 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(46.5 m)(100 m)(157.8 m)(167.2 m)

Accounts Receivable

(1.4 m)(3.6 m)8.5 m

Inventories

(1.6 m)(1.3 m)(3.1 m)7.1 m

Accounts Payable

(2.9 m)1.9 m661 k710 k

Cash From Operating Activities

(39.3 m)(80.9 m)(134 m)

Purchases of PP&E

(9.3 m)(12.5 m)(20.1 m)

Cash From Investing Activities

(35.5 m)(117.8 m)(64.8 m)

Cash From Financing Activities

74.3 m244 m181.8 m

Interest Paid

95 k
USDY, 2016

Revenue/Employee

146.8 k

Financial Leverage

1.1 x

EXACT Sciences Corporation Operating Metrics

FY, 2015

Patents Pending

57

Patents Issued

77

EXACT Sciences Corporation Market Value History

EXACT Sciences Corporation Online and Social Media Presence

EXACT Sciences Corporation Company Life and Culture

You may also be interested in